There are 2949 resources available
Exploring key safety data for cancer immunotherapy combinations
Presenter: Philippe Merle
Session: F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
Resources:
Webcast
Panel discussion
Presenter: Philippe Merle
Session: F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
Resources:
Webcast
Welcome and introduction
Presenter: Ghassan Abou-Alfa
Session: AstraZeneca - Current status and future directions for immunotherapy in hepatocellular carcinoma
Resources:
Webcast
Putting it all together: Case discussions
Presenter: Bruno Sangro
Session: AstraZeneca - Current status and future directions for immunotherapy in hepatocellular carcinoma
Resources:
Webcast
Clinical perspectives on a patient with advanced thyroid cancer
Presenter: Gilad Vainer
Session: Bayer - Precision medicine in Real-world clinical practice: Perspectives from a multidisciplinary team
Resources:
Webcast
Discussion and closing remarks
Presenter: Jean-Yves Blay
Session: Bayer - Precision medicine in Real-world clinical practice: Perspectives from a multidisciplinary team
Resources:
Webcast
Access, availability, and uptake of combination therapies in Europe
Presenter: Tim Wilsdon
Session: MSD - New approaches, old barriers: Will cancer patients get access to the combinations and early treatments they need?
Resources:
Webcast
Panel discussion moderated by Bettina Ryll
Presenter: Deepak Khanna
Session: MSD - New approaches, old barriers: Will cancer patients get access to the combinations and early treatments they need?
Resources:
Webcast
Tracking the recent advances within the field of unresectable HCC
Presenter: David Pinato
Session: F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
Resources:
Webcast
Moving into the clinic: how will these data inform our clinical decisions?
Presenter: Arndt Vogel
Session: F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
Resources:
Webcast